Jennifer W Evans Selected Research

Treatment-Resistant Depressive Disorder

1/2024	Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers.
12/2023	Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals.
9/2023	An exploration of actigraphy in the context of ketamine and treatment-resistant depression.
1/2020	A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer W Evans Research Topics

Disease

5	Major Depressive Disorder (Major Depressive Disorders) 01/2024 - 01/2018
4	Treatment-Resistant Depressive Disorder 01/2024 - 01/2020

Drug/Important Bio-Agent (IBA)

7	Ketamine FDA LinkGeneric 01/2024 - 01/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 01/2018
1	EsketamineIBA 01/2024
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	ProdrugsIBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	4-chlorokynurenineIBA 01/2020